Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04VRN
|
|||
| Former ID |
DNCL003249
|
|||
| Drug Name |
MMR
|
|||
| Indication | Measles [ICD-11: 1F03] | Phase 3 | [1] | |
| Mumps virus infection [ICD-11: 1D80; ICD-10: B26, B26.8] | Phase 3 | [1] | ||
| Rubella prophylaxis [ICD-11: 1F02; ICD-10: B06] | Phase 3 | [1] | ||
| Company |
GlaxoSmithKline
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C16H32N6O4S2
|
|||
| Canonical SMILES |
CSCCC(C(=O)NC(CCSC)C(=O)NC(CCCN=C(N)N)C(=O)O)N
|
|||
| InChI |
1S/C16H32N6O4S2/c1-27-8-5-10(17)13(23)21-11(6-9-28-2)14(24)22-12(15(25)26)4-3-7-20-16(18)19/h10-12H,3-9,17H2,1-2H3,(H,21,23)(H,22,24)(H,25,26)(H4,18,19,20)
|
|||
| InChIKey |
OXIWIYOJVNOKOV-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02184572) Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine inHealthy Children 12 to 15 Months of Age. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.